Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study - The Lancet Infectious
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study - The Lancet Infectious Diseases
Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 | MMWR
IJMS | Free Full-Text | Distinct Conformations of SARS-CoV-2 Omicron Spike Protein and Its Interaction with ACE2 and Antibody
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases
Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time | National Institutes of Health (NIH)
Why omicron is more infectious than other coronavirus variants | Science News
Frontiers | Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
Alpha, Beta, Gamma, Delta, Omicron: COVID-19 Variants Explained
Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study - The Lancet Infectious Diseases
Misguided drug advice for COVID-19 | Science
Study identifies current mechanism of action behind reduced severity of Omicron variant COVID-19 infection
Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study - The Lancet Infectious Diseases
Harvard advisers on Omicron, shifting protocols – Harvard Gazette
SARS-CoV-2 Omicron variant found to display increased resilience to antiviral type I interferon response
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England - The Lancet Infectious Diseases
Researchers unravel omicron's secrets to better understand COVID-19 – Washington University School of Medicine in St. Louis
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 | MMWR
Omicron seen as milder coronavirus but scientists aren't sure - Los Angeles Times
Pay attention to Omicron, worry more about Delta' | MUSC | Charleston, SC
Immune responses in Omicron breakthrough COVID-19
TaqPath COVID-19 Tests Support Detection of SARS-CoV-2 in Samples Containing the Omicron Variant - Clinical Conversations
